LINC00662 and central nervous system cancer: For glioma patients, Wu et al. (2020) showed that LINC00662 overexpression was related to both unfavorable clinical characteristics and poor prognoses; however, the silencing of LINC00662 was shown to suppress glioma cell proliferation and invasiveness in vitro.